ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

Publication date: Aug 31, 2023

Clinical Trials Registration ClinicalTrials. gov Identifier: NCT04518410.

Concepts Keywords
Covid ACTIV-2
Nct04518410 clinical trial
Outpatients COVID-19
Therapeutics COVID-19
Humans
monoclonal antibodies
Outpatients

Semantics

Type Source Name
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)